Epidemiological evolution of chronic hepatitis, liver cirrhosis and liver cancer in the Republic of Moldova

Sammendrag

Introduction. The burden of liver diseases is a major health issue, being underestimated both at the national and international level. In the Republic of Moldova, there are over 70 thousand patients with chronic hepatitis and over 10 thousand people suffering from liver cirrhosis. 70% of patients with cirrhosis develop liver cancer. Over 2,000 patients die annually from complications caused by liver cirrhosis, and over 400 patients die due to primary liver cancer.

Material and methods. The statistical analysis of 2000-2019 reports, presented by the Agency for Public Health, as well as of 3666 patient medical records retrieved from „Timofei Mosneaga” Republican Hospital, „Toma Ciorba” Clinical Hospital and “Sfinta Treime” Clinical Hospital was carried out.

Results. 89290 cases of chronic hepatitis, liver cirrhosis and liver cancer have been officially registered. Most of them exhibited a viral etiology. The death rate was mostly recorded in patients aged 70-79. The mean age of patients with chronic hepatitis was 57.74±11.22, liver cirrhosis - 56.21±10.17, and liver cancer- 59.05±10.94. The risk factors included unprotected sex, use of sharp objects, scissors and syringes, noncompliance with dietary regimens, alcohol and tobacco use, etc. Close relatives were also investigated for the presence of viral markers in only 38.81% of cases of chronic hepatitis and in 24.37% patients with liver cirrhosis

Conclusions. The study of common epidemiological evolution of chronic hepatitis, liver cirrhosis and primary liver cancer in the population, while considering the patient’s close relationship, might reduce both morbidity and medical and socio-economic impact.

PDF (English)

|Utsikt: 336| |PDF (English) Nedlastinger: 315|


PDF (English)

##plugins.generic.usageStats.downloads##

##plugins.generic.usageStats.noStats##

ANNOUNCEMENT

Starting from July 1, 2025, the article processing fee will be 20 EUR (or the equivalent in MDL at the official exchange rate of the National Bank of Moldova). The publication fee for an accepted article will be 150 EUR (or the equivalent in MDL).

Details here:

Processing Fee
A processing fee of 20 EUR (or the equivalent in MDL) will be charged for articles accepted for scientific review by the editorial committee of the One Health and Risk Management journal.
Note: This fee will only be charged if your article has been technically reviewed and accepted.

Publication Fee
Starting from 01.07.2025, a fee of 150 EUR (or the equivalent in MDL) will be charged for articles accepted for publication.
Additionally, authors will bear the cost of English language editing/translation services if the manuscript requires intervention. The fee is 5 EUR (or the equivalent in MDL) per page edited/translated.
The total cost for English editing/translation services will be communicated by the Editorial Board after the manuscript is accepted for publication.

Payment Details:
Payments should be made in MDL to the bank account opened in the name of the Biosafety and Biosecurity Association of the Republic of Moldova.
The invoice will be issued by the end of the month in which the payment was made.

Organization: Biosafety and Biosecurity Association of the Republic of Moldova
Address: 5C A. Cozmescu Street
Fiscal Code: 1017620004120
Bank Code (SWIFT): AGRNMD2X451
IBAN: MD34AG000000022513622370